Company intelligence / Profile preview

LifeTaq-Analytics

Tulln an der Donau / Klosterneuburg, Lower Austria, Austrialifetaq.com ↗

Ownership: Private
Development stage: Commercial

Overview

LifeTaq-Analytics has developed the Oli-Mat automated system to produce uniform, physiologically relevant scaffold-based human 3D cell models. These models closely mimic in vivo tissue behavior, providing more predictive power for drug discovery and toxicology studies. The system enables faster, more reliable, and ethical in vitro testing by standardizing cell cultures across batches.

Modalities: Device (automated 3D cell cultivation unit)Cell-based assay platform
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on LifeTaq-Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeTaq-Analytics.

Explore the full profile